Trial Profile
Dermatological analysis of teriflunomide-associated hair thinning to determine the severity of hair loss
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2019
Price :
$35
*
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 20 Aug 2015 New trial record
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.